Abstract
Breast cancer is the most frequently occurring cancer in women of reproductive age. Treatments for breast cancer may eliminate or diminish fertility, making discussions about fertility preservation essential prior to initiation of gonadotoxic therapies. Additionally, even in patients who do not require chemotherapy, the use of adjuvant endocrine therapy will often push patients out of the reproductive window before treatment is completed. The only established methods for fertility preservation are oocyte or embryo cryopreservation, but experimental methods, such as ovarian suppression with GnRH agonists and ovarian tissue cryopreservation, show great promise. Early referral to a fertility specialist for interested patients affords patients the most fertility preservation options, with only minimal delay to cancer treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Cancer Society (2015) Breast cancer facts & figures 2015-2016. American Cancer Society, Inc., Atlanta
Azim HA Jr, Kroman N, Paesmans M, Gelber S, Rotmensz N, Ameye L, De Mattos-Arruda L, Pistilli B, Pinto A, Jensen MB, Cordoba O, de Azambuja E, Goldhirsch A, Piccart MJ, Peccatori FA (2013) Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study. J Clin Oncol 31(1):73–79
Bedoschi G, Oktay K (2013) Current approach to fertility preservation by embryo cryopreservation. Fertil Steril 99(6):1496–1502
Boukaidi SA, Cooley A, Hardy A, Matthews L, Zelivianski S, Jeruss JS (2012) Impact of infertility regimens on breast cancer cells: follicle-stimulating hormone and luteinizing hormone lack a direct effect on breast cell proliferation in vitro. Fertil Steril 97(2):440–444
Cakmak H, Rosen MP (2015) Random-start ovarian stimulation in patients with cancer. Curr Opin Obstet Gynecol 27(3):215–221
Diaz de la Noval B (2016) Potential implications on female fertility and reproductive lifespan in BRCA germline mutation women. Arch Gynecol Obstet 294(5):1099–1103
Doyle JO, Richter KS, Lim J, Stillman RJ, Graham JR, Tucker MJ (2016) Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval. Fertil Steril 105(2):459–466 e452
Friedler S, Koc O, Gidoni Y, Raziel A, Ron-El R (2012) Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril 97(1):125–133
Fritz M, Speroff L (2011) Clinical gynecologic endocrinology and infertility, 8th edn. Lippincott Williams & Wilkins, Philadelphia
Goldfarb SB, Kamer SA, Oppong BA, Eaton A, Patil S, Junqueira MJ, Olcese C, Kelvin JF, Gemignani ML (2016) Fertility preservation for the young breast cancer patient. Ann Surg Oncol 23(5):1530–1536
Goncalves V, Quinn GP (2016) Review of fertility preservation issues for young women with breast cancer. Hum Fertil (Camb) 1–14
Jacobson MH, Mertens AC, Spencer JB, Manatunga AK, Howards PP (2016) Menses resumption after cancer treatment-induced amenorrhea occurs early or not at all. Fertil Steril 105(3):765–772 e764
Jeruss JS, Woodruff TK (2009) Preservation of fertility in patients with cancer. N Engl J Med 360(9):902–911. PMID: 19246362
Kasum M, von Wolff M, Franulic D, Cehic E, Klepac-Pulanic T, Oreskovic S, Juras J (2015) Fertility preservation options in breast cancer patients. Gynecol Endocrinol 31(11):846–851
Kim J, Oktay K, Gracia C, Lee S, Morse C, Mersereau JE (2012) Which patients pursue fertility preservation treatments? A multicenter analysis of the predictors of fertility preservation in women with breast cancer. Fertil Steril 97(3):671–676
Lambertini M, Ginsburg ES, Partridge AH (2015) Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy. Curr Opin Obstet Gynecol 27(1):98–107
Lee SJ, Schover LR, Partridge AH, Patrizio A, Wallace LN, Hagerty LV, Beck LN, Brennan LV, Oktay K, American Society of Clinical (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24(18):2917–2931
Llarena NC, Estevez SL, Tucker SL, Jeruss JS (2015) Impact of fertility concerns on tamoxifen initiation and persistence. JNCI J Natl Cancer Inst 107(10). PMID: 26307641
Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K, American Society of Clinical (2013) Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(19):2500–2510
McCray DK, Simpson AB, Flyckt R, Liu Y, O’Rourke C, Crowe JP, Grobmyer SR, Moore HC, Valente SA (2016) Fertility in women of reproductive age after breast cancer treatment: practice patterns and outcomes. Ann Surg Oncol 23(10):3175–3181
Oktay K, Kim JY, Barad D, Babayev SN (2009) Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol 28(2):240–244
Practice Committee of American Society for Reproductive (2013) Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril 100(5):1214–1223
Practice Committee of American Society for Reproductive (2014) Ovarian tissue cryopreservation: a committee opinion. Fertil Steril 101(5):1237–1243
Prasath EB, Chan ML, Wong WH, Lim CJ, Tharmalingam MD, Hendricks M, Loh SF, Chia YN (2014) First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. Hum Reprod 29(2):276–278
Reddy J, Oktay K (2012) Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer. Fertil Steril 98(6):1363–1369
Scanlon M, Blaes A, Geller M, Majhail NS, Lindgren B, Haddad T (2012) Patient satisfaction with physician discussions of treatment impact on fertility, menopause and sexual health among pre-menopausal women with cancer. J Cancer 3:217–225
Turan V, Bedoschi G, Moy F, Oktay K (2013) Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients. Fertil Steril 100(6):1681–1685 e1681
Waks AG, Partridge AH (2016) Fertility preservation in patients with breast cancer: necessity, methods, and safety. JNCCN 14(3):355–363
Wallace WH, Thomson AB, Saran F, Kelsey TW (2005) Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 62(3):738–744
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Constance, E.S., Moravek, M.B., Jeruss, J.S. (2018). Strategies to Maintain Fertility in Young Breast Cancer Patients. In: Gradishar, W. (eds) Optimizing Breast Cancer Management. Cancer Treatment and Research, vol 173. Springer, Cham. https://doi.org/10.1007/978-3-319-70197-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-70197-4_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-70195-0
Online ISBN: 978-3-319-70197-4
eBook Packages: MedicineMedicine (R0)